Chinopharma Ltd
34 IDL certificates:Been granted by NMPA from 2006 to 2017.
56 API products:Status "A" by Oct. of 2020.
41 API products:Status "I" by Oct. of 2020.
280 API products:To be filed.
52 products from India:Has been commercialized by end of 2018.
275 products: Exclusive agency agreements signed with over 100 pharmaceutical manufacturers.
+700 FDF customers:CSC has good business relationship in China market.
Over 50 million US dollars:CSC’s annual sales volume in 2018.
Over 3300 products &1000 companies:CSC built its own data base.